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Abstract Heparin and the related glycosaminoglycan, hep-
aran sulfate, are polydisperse linear polysaccharides that
mediate numerous biological processes due to their interac-
tion with proteins. Because of the structural complexity and
heterogeneity of heparin and heparan sulfate, digestion to
produce smaller oligosaccharides is commonly performed
prior to separation and analysis. Current techniques used to
monitor the extent of heparin depolymerization include UV
absorption to follow product formation and size exclusion or
strong anion exchange chromatography to monitor the size
distribution of the components in the digest solution. In this
study, we used
1H nuclear magnetic resonance (NMR)
survey spectra and NMR diffusion experiments in conjunc-
tion with UV absorption measurements to monitor heparin
depolymerization using the enzyme heparinase I. Diffusion
NMR does not require the physical separation of the
components in the reaction mixture and instead can be used
to monitor the reaction solution directly in the NMR tube.
Using diffusion NMR, the enzymatic reaction can be
stopped at the desired time point, maximizing the abundance
of larger oligosaccharides for protein-binding studies or
completion of the reaction if the goal of the study is
exhaustive digestion for characterization of the disaccharide
composition. In this study, porcine intestinal mucosa heparin
was depolymerized using the enzyme heparinase I. The
unsaturated bond formed by enzymatic cleavage serves as a
UV chromophore that can be used to monitor the progress of
the depolymerization and for the detection and quantification
of oligosaccharides in subsequent separations. The double
bond also introduces a unique multiplet with peaks at 5.973,
5.981, 5.990, and 5.998 ppm in the
1H-NMR spectrum
downfield of the anomeric region. This multiplet is produced
by the proton of the C-4 double bond of the non-reducing
end uronic acid at the cleavage site. Changes in this
resonance were used to monitor the progression of the
enzymatic digestion and compared to the profile obtained
from UV absorbance measurements. In addition, in situ
NMR diffusion measurements were explored for their ability
to profile the different-sized components generated over the
course of the digestion.
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Introduction
Heparin and heparan sulfate (HS) are long-chain un-
branched linear polysaccharides implicated in a wide range
of biological functions, including cell growth and prolifer-
ation, inhibition of angiogenesis, and tumor growth and
metastasis, as well as viral activity [1–3]. Heparin and HS
are members of the glycosaminoglycan (GAG) family of
carbohydrates, which also includes chondroitin sulfate,
dermatan sulfate, and keratan sulfate. Heparin is a highly
sulfated polysaccharide while HS is comprised of domains
of high and low sulfation partitioned by domains of
variable sulfation. Both polysaccharides have molecular
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disaccharide building blocks, a uronic acid residue α-linked
(1 → 4) to D-glucosamine (GlcN). While HS is predomi-
nantly found as a proteoglycan at the cell surface, heparin is
stored as a polysaccharide in secretory granules along with
histamine and mast cell proteases [4].
Although heparin and HS are biosynthesized from the
same disaccharide building block of glucuronic acid (GlcA)
and N-acetylglucosamine, as a result of modifications that
occur during chain extension, the end products are
heterogeneous with regard to chain length, charge, and
substitution pattern. In these GAGs, the uronic acid residue
may be either α-linked (1 → 4) L-iduronic acid (IdoA) or
β-linked (1 → 4) D-GlcA, which can be O-sulfo substituted
at the C-2 position. The α-linked (1 → 4) glucosamine can
be N-sulfonated, N-acetylated, or unmodified, with O-sulfo
substitution possible at the GlcN C-6 and, less commonly,
at the C-3 position [5]. Heparin is structurally simpler than
HS with approximately 70% of the disaccharide subunits
being IdoA(2S)-(1 → 4)-GlcNS(6S), commonly labeled as
disaccharide IS [4]. Because of their structural complexity
and heterogeneity, prior to analysis, heparin and HS are
typically exhaustively degraded enzymatically or chemical-
ly to their disaccharide building blocks, given in Fig. 1.
However, much of the current understanding of heparin
structure–activity relationships is obtained using larger
oligosaccharides.
Much of the interest in characterizing heparin structure is
focused on the determination of sequences that interact with
proteins and peptides. The interaction responsible for
heparin’s anticoagulant activity is the most studied and
best understood [6]. Binding of a unique heparin pentasac-
charide to antithrombin III (AT-III) induces a conformation
change in AT-III enhancing its affinity for thrombin and
coagulation factors IXa and Xa. The heparin pentasacchar-
ide sequence responsible for binding to AT-III is present in
only ∼30% of the intact heparin chains from porcine-
derived heparin [7, 8]. Many other heparin and HS
oligosaccharide sequences have been identified that bind
site specifically to a variety of proteins and peptides
modulating their function.
As mentioned above, a common approach to character-
izing heparin structure and identifying binding motifs is to
enzymatically or chemically depolymerize the heparin
biopolymer into smaller oligosaccharides which are isolated,
structurally characterized, and used in protein-binding experi-
ments. The availability of the heparin lyase enzymes heparin-
ase I, II, and III, isolated from Flavobacterium heparinum,
has greatly facilitated the analysis of both heparin and HS
[9]. The individual heparinase enzymes cleave unique
glycosidic linkages, allowing heparin and HS to be degraded
to specific oligosaccharide fragments [10]. Heparinase
cleavage introduces a Δ4,5-unsaturated double bond via a
β-elimination reaction at the non-reducing end uronic acid
residue of the newly generated saccharide, generating a
chromophore that can be detected by UV absorbance at
232 nm [11]. Chemical methods have also been established
for the depolymerization of heparin. These methods, used
commercially for the production of low molecular weight
heparin, include nitrous acid treatment [12, 13] (dalteparin),
base-catalyzed β-elimination [14, 15] (enoxaparin), peroxide
treatment [16] (ardeparin), and periodate oxidation [17]
(centaxarin).
Following either enzymatic or chemical depolymerization,
analysis of GAG digests typically proceeds via the physical
separation of the digest components based on differences in
their size and charge. UV and fluorescence detection work
well for the identification of GAGs at the disaccharide level
where standards are available; however, they do not provide
structural information for larger components. In cases where
larger oligosaccharides are targeted, digest solutions are
generally size-separated by size exclusion chromatography
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Fig. 1 Scheme illustrating the
enzymatic depolymerization
of heparin with the enzyme
heparinase I. The heparin-
derived oligosaccharide contains
a Δ
4,5 double bond introduced
into the uronic acid at the
non-reducing end.
594 J.F.K. Limtiaco et al.(SEC) to isolate corresponding disaccharide, tetrasaccharide,
hexasaccharide, and larger oligosaccharide fractions which
arefurtherpurifiedtoindividualoligosaccharidesusingstrong
anion exchange (SAX) [18–21] or reverse-phase ion-pair
high-performance liquid chromatography (HPLC) [22, 23].
Purified oligosaccharides can then be structurally character-
ized by nuclear magnetic resonance (NMR) spectroscopy
and mass spectrometry (MS).
In this study, we used
1H NMR spectra and diffusion
NMR results in conjunction with UVabsorbance at 232 nm
to monitor the enzymatic depolymerization of heparin using
heparinase I. Diffusion NMR, more specifically diffusion-
ordered spectroscopy (DOSY) [24], has recently been used
in the analysis of intact heparin samples to evaluate purity
and to identify both natural and intentional contaminants of
heparin [25, 26]. As demonstrated herein, diffusion NMR
allows the investigator to follow the extent of the enzymatic
reaction non-invasively and quench the digestion at the
desired endpoint.
Experimental
Materials and reagents
Porcine intestinal mucosa heparin sodium salt grade 1-A,
calcium acetate hydrate, ammonium bicarbonate, heparin
disaccharide ΔUA(2S)-(1 → 4)-GlcNS(6S) (IS) sodium
salt, and tris(hydroxymethyl)aminomethane (Tris) were
obtained from Sigma Chemical Company (St. Louis,
MO). Heparin disaccharide (IS) is the product of the
digestion of heparin and heparan sulfate with heparinase I
and II enzymes. Hydrochloric acid (HCl), tert-butanol, and
sodium hydroxide were obtained from Fisher Scientific Co.
(Fair Lawn, NJ). Heparinase I enzyme (EC 4.2.2.7) isolated
from F. heparinum was purchased from IBEX Technologies
Inc. (Montreal, Quebec). HPLC-grade water was purchased
from Burdick and Jackson (Muskegon, MI). Deuterium
oxide (D, 99.9%) was obtained from Cambridge Isotope
Laboratories (Andover, MA).
Enzymatic depolymerization of heparin
Digestion of 1 g heparin was carried out in 50 mL of
100 mM Tris buffer, pH 6.8, containing 2.5 mM calcium
acetate. The enzyme heparinase I (0.5 IU) was added to the
mixture and incubated at 28°C in a water bath for 66 h. One
international unit (IU) of the enzyme produces 1 μmol of
unsaturated uronic acid from porcine mucosal heparin per
min at 30°C and pH 7.0. The water bath temperature was
controlled using a Fisher Scientific Isotemp 1013S scien-
tific temperature regulator. The enzymatic reaction was
quenched by placing the reaction vessel into boiling water
for 5 min. The depolymerization solution was then
lyophilized and reconstituted into 15 mL of the separation
buffer (0.5 M NH4HCO3) prior to SEC separation.
Monitoring the progress of the enzymatic depolymerization
with UV absorption
During the 66-h enzymatic depolymerization, UV absorp-
tion measurements were taken at regular intervals (ranging
from 15 min to 6 h) to monitor the progress of the
enzymatic reaction. UV measurements were performed at a
wavelength of 232 nm using a Thermo Scientific Nano-
Drop 2000 spectrophotometer (Wilmington, DE). The
NanoDrop has a 1-mm path length requiring only 1 μLo f
sample. For absorption measurements above 1 AU, samples
were diluted by a factor of 2–4 times with the depolymer-
ization buffer prior to analysis. At 232 nm, the molar
extinction coefficient for the monounsaturated disaccharide
is 5,500 M
−1 cm
−1 [11]. Graphs were prepared using Origin
7.5 (OriginLab Northampton, MA).
SEC fractionation
The heparin-derived oligosaccharides were size-fractionated
on a column (200 cm×3.2 cm) packed with Bio-Rad Bio-Gel
P-10 resin fine (Bio-Rad Laboratories Hercules, CA) and
eluted with 0.5 M NH4HCO3 at a flow rate of 0.08 mL/min.
The total volume contained in each of the fractions collected
was 4.5 mL. The progress of the separation was monitored
offline by UVabsorption measurements at 232 nm using the
NanoDrop spectrophotometer as described above. Following
SEC, similar-sized fractions were pooled and stored as a
lyophilized powder at −20 °C for future use.
1H NMR experiments
Solutions for NMR analysis were prepared by adding
50 μLo fD 2O and 8 μL of 100 mM tert-butanol in D2O
to 550 μL of the depolymerization solution in a 5-mm
NMR tube. Solutions were mixed by gently tapping the
tube.
1H NMR spectra were recorded using a Bruker
Avance spectrometer operating at 599.84 MHz. All experi-
ments were performed using a broadband inverse probe
with x-, y-, and z-gradients. Chemical shifts were referenced
to tert-butanol (1.253 ppm) added as an internal reference.
For each
1H NMR spectrum, 64 transients were collected
into 26,624 data points using a 6,009-Hz spectral window
and a 2-s relaxation delay. NMR spectra were acquired
using the 1D wet pulse program (WET) included with the
standard Topspin release version 1.3 [27]. The automated
Bruker shape tool was used to create the sinc pulse for
selective excitation of the H2O resonance.
1H NMR spectra
were processed using the academic edition of the ACD/
NMR methods to monitor the enzymatic depolymerization of heparin 595Labs 1D NMR processing software, version 12.01. Prior to
Fourier transformation, the free induction decays (FIDs)
were zero filled to 65,536 points and apodized by
multiplication with an exponential function equivalent to
1-Hz line broadening. The reaction solution was maintained
at a temperature of 28 °C using the temperature control unit
of the NMR spectrometer. The spectrometer was initially
shimmed using a volume-matched solution of tert-butanol
in the depolymerization buffer, with the reaction solution
used for final optimization of the shims. The first spectrum
was acquired at 10 min following a quick shim and
optimization of the sinc-shaped pulses for WET solvent
suppression. Subsequent spectra were manually initiated at
intervals of 10 min for the first hour of the digestion to a
total interval time of 8 h. From the
1H NMR spectra
acquired throughout the course of the digestion, the peak
area of the N-acetyl resonance was fit using the ACD NMR
processing software and the calculated areas were normal-
ized to the fitted area of the tert-butanol resonance. These
normalized areas were used to compare the relative
intensities between the subsequent spectra.
The calibration of the z-gradient coil used for the diffusion
measurements was checked using the known diffusion
coefficient for lysozyme (1.07×10
−11 m
2/s) at 20 °C and a
concentration of 5 mg/mL prepared in D2O[ 28]. Diffusion
spectra were acquired using the stimulated echo experiment
with bipolar gradients (stebpgp1s). Diffusion (Δ)a n d
gradient pulse times (δ)w e r eo p t i m i z e df o re a c ht i m ep o i n t
using a one-dimensional version of the stimulated echo pulse
program, stepgp1s1d. Gradient amplitudes were incremented
as a square dependence from 5% to 95% into 12 or 18
gradient increments. Following acquisition, the FIDs were
apodized by multiplication with an exponential function
equivalent to 1.5-Hz line broadening and baseline-corrected
using a first-order polynomial prior to DOSY processing
using the DOSY Toolbox software [29]. Reference decon-
volution was performed on a few spectra but resulted in
significant errors in the fitting of the decay plots and was
therefore not used in the processing.
Because the diffusion spectra were acquired in a solution
of 90% water, it was necessary to eliminate the first
spectrum corresponding to a gradient field strength of
1.686 G cm
−1 before DOSY processing. By eliminating the
spectrum for the first gradient increment, we were able to
drastically attenuate the water peak, permitting the mea-
surement of the diffusion coefficients for the nearby H-4
and anomeric proton resonances. To simplify the DOSY
analysis, processing was carried out on individual spectral
regions of interest corresponding to the H-4, anomeric, and
N-acetyl resonances. We found this helpful especially when
processing later experiments, after the first day of the
digestion, as these spectra were observed to be more
complex in terms of the size distribution of the heparin
oligosaccharides. Peaks above a manually set threshold
level were automatically picked by the DOSY Toolbox
software for DOSY processing. Peaks were then fit to a
standard monoexponential decay (HR-DOSY) with a
diffusion resolution of 256 points. Fitting statistics for the
pure exponential fitting to the Stejskal–Tanner equation for
the diffusion coefficients and fitting errors were determined
and displayed following the DOSY processing.
Results and discussion
The commercially available heparinase enzymes I, II, and
III, each with unique specificity, are commonly used for
heparin and HS digestions. Heparinase I cleaves the GlcNS
(6S) → IdoA(2S) glycosidic bond and is considered
specific for the analysis of heparin [4, 6, 30]. Heparinase
III is most active for 2-OH GlcA-containing glycosidic
linkages and therefore is used for HS digestion [4].
Although heparinase III tolerates 6-O sulfonation, it does
not act on IdoA residues containing 2-O-sulfo substituents
[9]. Heparinase II has broader substrate specificity cleaving
a wide range of disaccharide repeat units with either 2-O-
sulfo or 2-OH at the uronic acid [4]. Because heparinase II
has been reported to have two distinct active sites, one
which is heparinase I like and the other heparinase III like,
it can be used for the analysis of both heparin and HS [9].
Exhaustive depolymerization of heparin is often carried out
using a cocktail containing all three enzymes.
Monitoring the enzymatic depolymerization with UV
absorption
Cleavage of the heparin polysaccharide with heparinase
enzymes introduces an unsaturated bond between C-4 and
C-5 of the non-reducing end uronic acid, as shown in
Fig. 1. By exploiting the UV absorbance of the double-
bond-containing product, the progress of the reaction can
be monitored as shown in Fig. 2a. In our hands, the results
of heparinase digestions are highly variable and the extent
of the reaction can be difficult to predict. The heparinase
enzymes are not very stable and the point at which product
formation plateaus in a digestion depends both on the
consumption of reactant and the loss of enzymatic activity.
If the 1 g heparin sample had been completely depoly-
merized to disaccharides by the 50 units of heparinase I
used in this experiment, a product concentration of roughly
34 mM would be predicted. Obviously, the value expected
would be less than this value, as some disaccharide
sequences will not fit the consensus sequence required for
heparinase I activity. The reaction shown in Fig. 2a was
considered complete after 66 h as indicated by a plateau in
the product concentration at 7.92 mM. If the goal of this
596 J.F.K. Limtiaco et al.digestion had been to produce mostly larger oligosacchar-
ides for protein-binding studies, it could have been
desirable to quench the reaction prior to its plateau.
Following the enzymatic digestion, an SEC separation
was performed to determine the size dispersion of the
resulting heparin oligosaccharides and fractionate the
products based on size. The 50-mL heparinase digest
solution was lyophilized, reconstituted into 15 mL of the
separation buffer (0.5 M NH4HCO3), and applied to a
preparative-scale SEC column for separation. A column
void volume of 346.5 mL was observed before the initial
elution of the largest isolated oligosaccharide; the hexade-
casaccharides (dp16) present in fractions 77–81.
The progress of the size separation was monitored by
UV absorbance measurements plotted as effective double-
bond concentration vs. SEC fraction in Fig. 2b.T h e
resolution obtained provided an efficient separation even
for the largest oligosaccharides. As can be seen from the
SEC, completion of the reaction did not correspond to
complete digestion of heparin to its corresponding disac-
charide subunits as expected for heparinase I. The SEC
peak with the highest concentration corresponds to the
disaccharide component (dp2). Preceding peaks correspond
to larger heparin oligosaccharides ranging from tetrasac-
charides (dp4) to hexadecasaccharides (dp16), with each
SEC fraction containing a heterogeneous mixture of
similarly sized oligosaccharides varying in their disaccha-
ride compositions.
Monitoring the enzymatic depolymerization of heparin
with
1HN M R
In addition to following the enzymatic digestion using UV
absorbance,
1H NMR spectra were acquired at various
points throughout the reaction. Although NMR has been
used extensively in the characterization of heparin-derived
oligosaccharides [20, 31–33], to our knowledge, there has
only been one study that used NMR to monitor heparin
depolymerization [20]. Chuang et al. used
1H-NMR to
monitor the kinetics of heparinase digestions with and
without histamine present and to identify the oligosaccha-
ride fragments that were bound to histamine in the digest
solution.
In this study,
1H NMR was also used to follow the
progress of the heparinase I enzymatic digestion. The digest
solution was left in the NMR probe for the duration of the
reaction to maintain temperature control and to avoid
extensive shimming between acquisitions. Figure 3 shows
a sample of the
1H NMR spectra measured as a function of
reaction time. Near the start of the reaction (10 min), the
spectra are essentially those of intact heparin. The heparin
resonances are broad due in large part to the short T2 values
of the large biopolymer (MW∼17–19 kDa). Heparin
resonance line widths are also affected by binding of trace
paramagnetic impurities, and addition of small amounts of
deuterated EDTA can significantly improve spectral quality
[34]. However, because heparinase I requires Ca
2+ for
activity, EDTA could not be added to the reaction solution
[35].
As the reaction proceeded, heparin oligosaccharide
resonances corresponding to the digested heparin fragments
were observed at chemical shifts of 5.973, 5.981, 5.990,
and 5.998 ppm, consistent with results reported by Chuang
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Fig. 2 Generation of heparin-derived oligosaccharides. a Progression
of the enzymatic digestion measured at 232 nm using a 1-mm sample
length. Aliquots were taken at regular intervals (15 min to 6 h). b
Preparative SEC of heparin oligosaccharides following the enzymatic
depolymerization of heparin with heparinase I. The labels represent
the number of saccharide units in the depolymerization products with
dp2 corresponding to disaccharides, dp4 to tetrasaccharides, etc.
Product concentrations were calculated using the measured absor-
bance and the molar extinction coefficient for the monounsaturated
disaccharide of 5,500 M
−1 cm
−1.
NMR methods to monitor the enzymatic depolymerization of heparin 597[20]. These resonances correspond to oligosaccharides
produced by the β-elimination reaction and containing a
double-bond proton, H-4, at the C-4 position of the non-
reducing end uronic acid at the cleavage site. As expected,
the intensities of the H-4 resonances increased as the
reaction progressed, although the rate of increase was
different for the different peaks. The resonances at 5.990
and 5.998 ppm were observed to increase at a faster rate
than the resonances at 5.973 and 5.981 ppm during the first
12 h of the digestion. As the reaction progressed, as
indicated by the increase in UV absorption, the upfield
resonances continued to increase and at 48 h the resonances
at 5.973 and 5.981 ppm were similar in intensity to the
resonances at 5.990 and 5.998 ppm as shown in the inset of
Fig. 3. The two upfield resonances at 5.973 and 5.981 ppm
are also more narrow, suggesting that these resonances may
arise from smaller oligosaccharide fragments.
In addition to monitoring the H-4 protons, we were also
interested in identifying additional resonances which act as
signatures of heparinase I digestion, especially resonances
for the H-1 protons of the heparin oligosaccharides. Two
new resonances in the anomeric region of the spectrum at
5.460 and 5.514 ppm, indicated by the arrows in Fig. 3,
were also observed to increase as the reaction progressed.
HOD Tris Acetate
N-acetyl
66 hr
48 hr
12 hr
10 min
6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0
6.000 5.975
6.000 5.975
6.000 5.975
6.000 5.975
6.000 5.975
6.000 5.975
6.000 5.975
Fig. 3
1H NMR spectra mea-
sured as a function of time for
the depolymerization solution.
Acetate was introduced into the
solution as calcium acetate be-
cause the enzyme requires cal-
cium for activity. Tris was added
as the buffering salt at a pH of
6.8. Insets correspond to the H-4
resonances of the Δ
4,5 double
bond introduced during diges-
tion. Arrows indicate the signa-
ture peaks used for the NMR
diffusion measurements.
Anomeric peaks at 5.460 and
5.514 ppm correspond to the
formation of ΔUA(2S)-(1 → 4)-
GlcNS(6S).
598 J.F.K. Limtiaco et al.In concert with the increase in intensity of these resonances,
the anomeric resonances for the intact heparin at 5.230 and
5.415 ppm diminished over time. The increased intensity of
the H-1 resonances at 5.460 and 5.514 ppm indicates a
significant increase in the amount of ΔUA(2S)-(1 → 4)-
GlcNS(6S), disaccharide IS, the primary disaccharide
building block of heparin containing a double bond as a
result of the enzymatic cleavage.
Monitoring the enzymatic depolymerization of heparin
using DOSY
The NMR diffusion experiments were performed using
dilute aqueous solutions of heparin. Because the diffusion
behavior of solution components is related to hydrodynam-
ic properties such as size, shape, and charge, solution
components can be distinguished provided that the species
have resolved resonances or significantly different diffusion
coefficients [36–38]. DOSY is commonly used to process
and display diffusion data. DOSY spectra are calculated
using an approximation to the inverse Laplace transform
from a series of pulsed-field gradient NMR spectra acquired
using gradient pulses with varying amplitudes. DOSY
processing produces a pseudo-2D spectrum with NMR
chemical shifts on the horizontal axis and calculated self-
diffusion coefficients along the vertical axis, resolving the
spectra of the individual components based on their
diffusion behavior [24, 39, 40].
DOSY NMR lends itself to monitoring reactions directly
in the NMR tube. No physical separation of mixture
components is required, and reaction components can be
identified by virtue of their
1H NMR resonances and
diffusion coefficients. These experiments used the bipolar
pulse-pair-stimulated echo experiment (BPPSTE) [41]. The
stimulated echo sequence avoids phase modulation of
coupled resonances by storing the magnetization along the
longitudinal axis during the diffusion delay, while the use
of bipolar gradients reduces the effect of eddy currents and
corresponding lock disturbances. Diffusion coefficients
were calculated for individual resonances in the BPPSTE
spectra by measuring signal attenuation as a function of
gradient amplitude. Signal intensities were fit to the
Stejskal–Tanner equation modified for the BPPSTE pulse
sequence, as shown in Eq. 1,
I ¼ Io exp  DðgdGÞ
2 Δ  
d
2
 
t
3
 
ð1Þ
where D is the diffusion coefficient, I is the resonance
intensity measured for a given gradient amplitude, G, I0 is
the intensity in the absence of the gradient pulse, γ is the
gyromagnetic ratio of the nucleus detected, δ is the duration
of the bipolar gradient pulse pair, Δ is the diffusion delay
time, and τ is a short gradient recovery delay during which
relaxation and spin–spincouplingevolutionarenotsignificant.
Although interactions of heparin and HS with proteins
and peptides is considered primarily electrostatic, involving
interactions between the cationic ammonium, guanidinium,
and imidazolium side chains of proteins and peptides with
the anionic sites on heparin and HS, binding through
unique heparin and HS structural motifs is also important
for biological activity [4]. The exhaustive digestion of
heparin significantly affects the biological activity of the
oligosaccharides produced by eliminating binding specific-
ity [42, 43]. Depolymerization reaction monitoring is
currently performed using analytical-scale SEC or SAX
separations with UV detection to determine the oligosac-
charide size distribution as a function of time [18, 44].
These separations are time consuming and wasteful of
sample as each measurement requires extraction of an
aliquot from the depolymerization reaction solution.
DOSY has traditionally been used for the analysis and
characterization of mixtures and aggregates [24, 39, 45–
47]; however, the Morris group recently reported the use of
DOSY to follow the acid hydrolysis of sucrose and
maltotriose [48, 49]. To our knowledge, DOSY has not
been used to monitor heparinase digestions; therefore, we
designed experiments to test the ability of DOSY to follow the
heparin depolymerization reactionin situ.If successful, DOSY
could be used to monitor the size distribution of oligosacchar-
ides produced as the enzymatic reaction proceeds. This would
allow the investigator to quench the reaction at the optimum
time to maximize the yield of the larger oligosaccharides most
relevant for heparin-binding studies.
A portion of the DOSY spectra measured for the digest
samples at1 and 66hare shown inFig.4a, b,r e s p e c t i v e l y .A t
1 h, only two major heparin anomeric resonances are
observed in the DOSY spectrum (Fig. 4a). These peaks give
rise to similar diffusion coefficients 1.03±0.02×10
−10 and
1.04±0.02×10
−10 m
2 s
−1 for the proton resonances at 5.230
and 5.415 ppm, respectively. The diffusion coefficients are
larger than values reported previously for intact heparin
(∼4.5×10
−11 m
2 s
−1)[ 25]. This may be attributed to the
slightly higher temperature used in the digestion as well as
differences in the buffer concentration, heparin source, and
the solution viscosities for water (1.00 mPa s) and deuterium
oxide (1.25 mPa s). After 1 h, the H-4 resonances can barely
be detected above the noise and are too weak to provide a
reliable DOSY fit.
The DOSY spectrum measured after 66 h, Fig. 4b,s h o w s
much greater variability in the calculated diffusion coef-
ficients. Regions of the spectrum were fit individually to
reduce the complexity of the analysis. Peaks above a
manually set threshold level were automatically selected
and fit with a monoexponential decay using the DOSY
Toolbox software. In addition to calculating diffusion
NMR methods to monitor the enzymatic depolymerization of heparin 599coefficients and fitting errors, residual plots for each of the
fitted peaks were also available to evaluate the fitting model.
From the SEC separation obtained for the bulk digestion
solution at the completion of the reaction, it is evident that
the digestion solution is a heterogeneous mixture dominated
by smaller disaccharide and tetrasaccharide components.
Therefore, the resonances in the
1HN M Ra n dD O S Ys p e c t r a
are produced by multiple oligosaccharide components with
different molecular weights but similar structures. It is
possible to use routines such as CONTIN [50, 51], CORE
[52], and multivariate approaches [53, 54] to fit diffusion
data measured for polydisperse components such as poly-
mers or aggregates to a distribution of diffusion coefficients.
However, for the diffusion spectra shown in Fig. 4,a
monoexponential fit of Eq. 1 to the data provides acceptable
fits yielding average diffusion coefficients and reasonable
fitting errors from 1.5% to 6%.
As the digestion progressed, diffusion coefficients were
monitored for the anomeric resonances of the intact heparin
(5.230 and 5.415 ppm) and the H-4 resonances (5.973,
5.981, 5.990, and 5.998 ppm) of the cleaved product, as
well as N-acetyl peaks (2.048 ppm) of the heparin
oligosaccharides. The values obtained over the course of
the experiments are consistent with what is expected for an
enzymatic digestion; as the reaction proceeded, the mea-
sured diffusion coefficients for all peaks were observed to
increase. This observation is expected as larger heparin
oligosaccharides are continually cleaved into smaller frag-
ments throughout the digestion, thus increasing their
individual mobilities in the solution. Though the diffusion
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Fig. 4 DOSY spectra for the
anomeric and H-4 protons of
the ΔUA residues of the heparin
digest solution at a 1h
and b 66 h.
600 J.F.K. Limtiaco et al.coefficient for the N-acetyl resonance changed over the
course of the digestion from an initial value of 1.04±0.01×
10
−10 m
2 s
−1 at 1 h to 4.24±0.08×10
−10 m
2 s
−1 at 66 h, its
intensity remained constant throughout the digestion with
an average intensity of 0.377±0.03 normalized to the
intensity of tert-butanol.
Diffusion coefficients measured for the H-4 and the H-1
resonances associated with the digested heparin oligosac-
charides also increased over the course of the digestion.
Four hours following the initiation of the reaction,
integration of the H-4 resonances at 5.990 and 5.998 ppm
was possible, producing diffusion coefficients of 1.681±
0.19×10
−10 and 1.37±0.17×10
−10 m
2 s
−1, respectively.
Fitting of the H-4 resonances at 5.973 and 5.981 ppm was
possible only after 13 h, producing diffusion coefficients of
5.77±0.76×10
−10 and 3.14±0.26×10
−10 m
2 s
−1, respec-
tively. The larger fitting errors obtained for the 4 and 13 h
data reflect the greater heterogeneity of the product in these
solutions and the fact that the enzymatic reaction is
continuing during the 2 h required for acquisition of the
diffusion data set. At the conclusion of the digestion, the
measured diffusion coefficients for the H-4 resonances
ranged from 4.87±0.15×10
−10 to 7.78±0.46×10
−10 m
2 s
−1
for the peaks at 5.990 and 5.973 ppm, respectively, as
shown in Fig. 4b.
Differences observed between the diffusion coefficients
determined for the N-acetyl, H-4, and anomeric resonances
can be attributed to a reduced activity of the enzyme for
heparin species low in sulfation, for example, heparin
fragments containing an acetylated glucosamine residue [4].
Throughout the digestion, the components with upfield H-4
resonances (5.973 and 5.981 ppm) were observed to diffuse
faster than components corresponding to the downfield
6.1 6.0 5.9 5.8 5.7 5.6 5.5 5.4 5.3 5.2 5.1
a 
b 
Chemical Shift (ppm)
Fig. 5
1H NMR spectra of the
anomeric region a standard IS
disaccharide of heparin mea-
sured in depolymerization buffer
and b heparin depolymerization
solution at time 66 h. Spectra
acquired with 64 scans using
WET for the suppression of the
water resonance.
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Fig. 6 The diffusion coefficients for the H-4 protons of the ΔUA
residues at 5.973 (squares), 5.981 (circles), 5.990 (inverse triangles),
and 5.998 (upright triangles) formed during heparinase I digestion.
NMR methods to monitor the enzymatic depolymerization of heparin 601resonances (5.990 and 5.998 ppm) as shown in Fig. 4b. The
H-4 resonance is a doublet of doublets with a larger
coupling of around 4 Hz, observed in these spectra due to
coupling to the H-3 proton of the uronic acid, and a <1 Hz
long-range coupling to H-2 not visible in these spectra due
to the apodization function applied. The heterogeneity of
the components giving rise to the H-4 peaks in the digest
solution is also apparent from the varied intensities of the
peaks. Clearly, even at 66 h, the spectrum contains H-4
resonances from more than two components. Because
heparin is primarily composed of the disaccharide IdoA
(2S)-(1 → 4)-GlcNS(6S), the
1H NMR spectrum of the IS
standard in the depolymerization buffer was measured for
comparison with that of the heparin depolymerization
solution as shown in Fig. 5. From the overlay of the two
spectra, it is evident that a major component of the
digestion mixture is the disaccharide IS.
Figure 6 compares the diffusion coefficients measured
using the H-4 resonances as a function of reaction time.
Linear regression (R≥0.93) of the data indicated a strong
correlation between the diffusion coefficients and reaction
time. Such a calibration plot could be useful for inves-
tigators wishing to quench the enzymatic digestion to
maximize the yield of product with a desired size
distribution. It is also interesting to note from the plot that,
although the diffusion coefficients for the resonances at
5.981, 5.990, and 5.998 ppm appear to begin to level out
toward the conclusion of the reaction, the diffusion
coefficient measured for the resonance at 5.973 ppm
continues to increase. These DOSY results may provide
insight into the possible mode of action for heparinase I, as
the digestion results from the repetitive binding and
cleavage of larger fragments in the digest solution.
Conclusions
In this study, NMR provided a mechanism to monitor the
enzymatic depolymerization of heparin in situ. In conjunc-
tion with UV absorption measurements, DOSY provided
insight into the extent of reaction and the size distribution
of the heparin oligosaccharides produced along the course
of the digestion. The ability to monitor diffusion coeffi-
cients, which report on the size distribution of heparin-
derived oligosaccharides, provides a means for the inves-
tigator to quench the reaction at an optimum time to
maximize the yields of larger oligosaccharides most
relevant for heparin-binding studies.
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